Article

Femtosecond platform provides precise capsulotomies

A femtosecond laser platform (Victus, Bausch + Lomb/Technolas Perfect Vision) provides high-quality capsulotomies that are round, precise, and completely cut, and use of the system is associated with a short learning curve, said Soon-Phaik Chee, MD.

Chicago-A femtosecond laser platform (Victus, Bausch + Lomb/Technolas Perfect Vision) provides high-quality capsulotomies that are round, precise, and completely cut, and use of the system is associated with a short learning curve, said Soon-Phaik Chee, MD.

“The greatest surgical challenge in cataract surgery is creating a perfect centered capsulorhexis that is of the desired size to overlap the optic homogenously,” said Dr. Chee, of the Singapore Eye Centre.

Dr. Chee and her colleagues performed an observational study to evaluate the size and centration of the capsulotomy in nine eyes with an intended rhexis of 5 mm. After an IOL was implanted, she evaluated the circularity of the capsulorhexis created using the laser, the intended diameter versus the achieved diameter, and the centration of the capsulorhexis.

The circularity of the laser capsulorhexis was a mean of 0.996 compared with the intended value 1.0, which represents a perfect circle, she said. The capsulorhexis diameter was 4.968 versus the intended 5.0 for a perfect circle. She also noted that the centration was very accurate.

“The quality of the capsulotomy is always a concern,” Dr. Chee said. “In the study, the capsulotomies were round, precise, and completely cut. Most of the rhexes were also free-floating.

“I found the [femtosecond laser] system to be very easy to use and safe,” she added. “There was a short learning curve, considering that I am a cataract surgeon who never performed a refractive surgery.”

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.